Navigation Links
Codexis Reports First Quarter 2011 Results
Date:5/5/2011

ear career in the U.S. Congress.

On January 25, 2011, Codexis signed its first Japanese biocatalysis collaboration with Dainippon Sumitomo Pharma, one of the ten largest Japanese pharmaceutical manufacturers. Under the agreement, Codexis will supply biocatalysis screening products and services to DSP for use in selected undisclosed therapeutic products in its development pipeline.

On January 12, 2011, Codexis signed an enzyme supply agreement with DSM Pharmaceutical Products, the custom manufacturing organization of Royal DSM NV.  The agreement grants DSM rights to use Codexis' custom biocatalysts and services, and secures supply of Codexis enzymes for commercialization of sustainable enzyme-based pharmaceutical manufacturing routes developed by DSM's InnoSyn™ route scouting services.

Conference CallCodexis will hold a conference call for investors on May 5, 2011 at 1:30 p.m. PT (4:30 p.m. ET). The conference call dial-in numbers are US: 866-730-5771 or International: 857-350-1595, access code 43195209. A live webcast of the call will also be available from the Investor Relations section of www.codexis.com. A recording of the call will be available by calling US: 888-286-8010 or International: 617-801-6888, access code 62515565 beginning approximately two hours after the call, and will be available for up to thirty days. A webcast replay from today's call will also be available from the Investor Relations section of www.codexis.com approximately two hours after the call and will be available for up to thirty days.

About Codexis, Inc.Codexis is a clean technology company. Codexis develops optimized biocatalysts that make industrial processes faster, cleaner and more efficient. Codexis' technology is commercialized with leading global pharmaceutical companies and in development for advanced biofuels with Shell and carbon capture. Other potential ma
'/>"/>

SOURCE Codexis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Former Senator Byron Dorgan Elected to Codexis Board
2. Codexis Reports Fourth Quarter and Full Year 2010 Results
3. Codexis Grows Revenue 35 Percent in Third Quarter; Raises 2010 Outlook
4. Codexis Names Vonnie Estes to New Technology Strategic Planning VP Role
5. Codexis R&D Productivity Panels Also Used By Roche
6. Codexis Names Lori Giver VP Systems Biology
7. Codexis, Teva in Licensing Agreement Final
8. Codexis Names Vice President, Intellectual Property
9. Codexis, Arch Announce Expanded Collaboration
10. Vanda Pharmaceuticals Reports First Quarter 2011 Results
11. Reportlinker Adds Genetics Reports Bundle
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... Scotland , June 2, 2015 ... addressing the global antibiotic resistance problem  ... novel class of anti-infectives, to address the major ... it has developed a stable intravenous (IV) formulation ... and resistant Gram-positive hospital-acquired infections.  The intravenous ...
(Date:6/1/2015)... 02, 2015 Chosen for his ... Jack Uldrich has been selected as keynote speaker ... today. He will deliver his keynote: "Don't Stop ... delivered presentations to the American Medical Association, Blue ... Neurology, Alcetel-Lucent/Verizon Forum on Wireless Healthcare, United Healthcare, ...
(Date:6/1/2015)... South Korea , June 1, 2015 ... Cross Biotherapeutics Inc. (GCBT) kicked off construction today on ... Montreal Technoparc,s Saint-Laurent Campus. The CA$315 million project represents ... Canada in the biopharmaceutical industry, ... immunoglobulin (IVIG) and albumin manufacturing plant in ...
(Date:6/1/2015)... NEW YORK , June 1, 2015 ... produced by the fermentation of sugar or cellulose. Bio-alcohols ... bio-ethanol can be used as a replacement for gasoline ... to grow at a CAGR of 9 percent over ... Report The global bio-alcohols market can be segmented into ...
Breaking Biology Technology:MGB Biopharma Succeeds in Developing an IV Formulation of MGB-BP-3 for the Treatment of Systemic Susceptible and Resistant Gram-Positive Hospital-Acquired Infections 2MGB Biopharma Succeeds in Developing an IV Formulation of MGB-BP-3 for the Treatment of Systemic Susceptible and Resistant Gram-Positive Hospital-Acquired Infections 3Futurist Jack Uldrich to Address the Future of Pharmaceuticals 2Green Cross Biotherapeutics Kicks Off Construction in Montreal 2Green Cross Biotherapeutics Kicks Off Construction in Montreal 3Global Bio-alcohols Market 2015-2019 2
... June 30 SeqWright Inc., a ... services, announced today the expansion of its service ... the company,s innovative RainStorm™ microdroplet-based PCR technology.  SeqWright ... for more efficient and cost-effective processes that allow ...
... ... an agreement under which Therapure will provide development services for Diamedica ... terms of the agreement, Therapure will provide cell line development and ... products, a protein which may be used for the treatment of ...
... width of a human hair are a key component in ... in the cosmos, and they have now arrived at the ... and they are tiny doorways that focus the attention of ... others. They will focus in on objects like very distant ...
Cached Biology Technology:SeqWright Expands Genomics Services Offering Through New Partnership With RainDance Technologies 2Therapure Biopharma Inc. Signs Biomanufacturing Contract with Diamedica Incorporated 2ESA to set tiny hair-like Webb Telescope microshutters 2
(Date:5/28/2015)... , May 28, 2015 Industry analyst ... a new report titled "Markets for Self-Healing Materials: ... inorganic capsule and vascular systems, biomaterials, relevant shape ... to around $2.7 billion by 2020. ... extensive coverage of smart materials. Other recent n-tech reports ...
(Date:5/22/2015)... 22, 2015 According to a ... (2D, 3D, Thermal, Emotion, Forensic), by Software (Middleware, Databases), by ... Utilities, Consumer and Home) - Global Forecast to 2020", ... $2.77 Billion in 2015 to $6.19 Billion by 2020, ... 79 market data Tables and   43 Figures spread ...
(Date:5/19/2015)... GOTHENBURG, Sweden , May 18, 2015 ... touch fingerprint sensors FPC1020, FPC1025, FPC1145, FPC1155 and FPC1035 from ... place from June until and including Q3 2015 and the ... Asia . Communicated order values for 2015 hereby amount ... revenues for Q1 2015 of 140 MSEK and a number ...
Breaking Biology News(10 mins):The Market for Self-Healing Materials to Reach $2.7 Billion by 2020 Says New n-tech Research Study 2The Market for Self-Healing Materials to Reach $2.7 Billion by 2020 Says New n-tech Research Study 3Facial Recognition Market Worth $6.19 Billion by 2020 2Facial Recognition Market Worth $6.19 Billion by 2020 3Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2
... long believed that bigger is better when it comes to ... dinosaurs, have evolved into larger species over time. , ... the University of California, San Diego in an early online ... suggests that maxim, known as "Cope's Rule," may be only ...
... have discovered that butterflies experience a great loss in ... findings appear in the March issue of the Journal ... Molecular Biology journal. , "The transformation of a caterpillar ... says William E. Connor of the Oregon Health and ...
... February 15th issue of Genes & Development lends novel ... while they reside in the female reproductive tract ?providing ... fertilization. , It had been believed for decades that ... Haim Breitbart (Bar-Ilan University, Israel) now show that, in ...
Cached Biology News:Study finds evolution doesn't always favor bigger animals 2Study finds evolution doesn't always favor bigger animals 3Butterflies lose body fat during metamorphosis 2
... CELlulose) was developed in the late 1960s ... of the earliest commercial pioneers of immunoassay ... range in 1987. Sac-Cel rapidly found favour ... own "in house" radioimmunoassays, and became a ...
Determin interaction of your protein with Echelons lipids...
... Eppendorf Reference Series 2000 Pipette is a ... a compact and robust design, and superior ... used to operate the measuring stroke and ... Product features:Eppendorf "pipette/tip" system ensures utmost accuracy ...
Identify and characterize Phosphoinositide (PI(3,4,5)P3) binding...
Biology Products: